Related Experiment Videos
Methodological concerns: evaluating central nervous system (CNS) active compounds in Alzheimer's disease (AD)
1Center for Aging & Alzheimer's, Beverly Hills, California 90211.
Progress in Clinical and Biological Research
|January 1, 1989
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach.
Journal of thrombosis and haemostasis : JTH·2013
Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit.
Journal of neural transmission (Vienna, Austria : 1996)·2002
Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine.
Cephalalgia : an international journal of headache·2001
DNA homology and chromosome stability: a sensitive yeast genetic system for identifying double-stranded DNA damage.
Progress in clinical and biological research·2018
Interaction of lipopolysaccharide with a mammalian lyso-phosphatidate acyltransferase (LPAAT) transfected into E. coli, and effect of lisofylline on LPAAT transfected into mammalian cells.
Progress in clinical and biological research·1998
The molecular basis for therapeutic concepts utilizing CD14.
Progress in clinical and biological research·1998
Endotoxin tolerance alters macrophage membrane regulatory G proteins.
Progress in clinical and biological research·1998
Molecular mechanisms responsible for endotoxin tolerance.
Progress in clinical and biological research·1998
Antibiotic-mediated release of endotoxin and the pathogenesis of gram-negative sepsis.
Progress in clinical and biological research·1998
In silico and In vitro studies of EGFR kinase and Anilide derivatives as inhibitors against Breast Cancer.
Biotechnology notes (Amsterdam, Netherlands)·2026
Comparative metabolomic and protective effects of Quercus leucotrichophora leaf and acorn extracts against doxorubicin-induced oxidative and inflammatory injury.
Journal of diabetes and metabolic disorders·2026